跳至主要内容
临床试验/NL-OMON31934
NL-OMON31934已完成不适用

Mannitol inhalations as a new procedure for testing of airways hyperresponsiveness - Mannitol en AHR

ongziekten0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Asthmatics:
  • - Episodic symptoms of dyspnea, and/or wheezing, and/or cough
  • - Allergic or non-allergic
  • - non current smokers (> 0.5 years)
  • - PC20 MCh < 8 mg/ml;COPD patients:
  • - Age > 40 yrs
  • - Active or former smokers, with a smoking history of more than 10 packyears
  • - Continuous symptoms of cough/sputum and/or dyspnea on exertion
  • - No history of asthma
  • - FEV1/FVC < 70 % and FEV1 between 50 and 80 % pred.;Controls
  • - No history of asthma or COPD
  • - PC20 MCh > 8 mg/ml
  • - FEV1/FVC > 70 % and FEV1 > 90 %pred.

排除标准

  • m- Age < 18 years
  • - Inability to perform acceptable-quality spirometry or to understand directions given by personnel
  • - Severe airflow limitation (FEV1 < 50% of predicted or < 1.0 L)
  • - Heart attack or stroke in last 6 months
  • - Uncontrolled hypertension, systolic BP > 200, or diastolic BP > 100
  • - Known aortic aneurysm
  • - Pregnancy
  • - Nursing mothers
  • - Current use of cholinesterase inhibitor medication (for myasthenia gravis)

研究者

发起方
ongziekten

相似试验